Issued Patents All Time
Showing 1–25 of 34 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12319698 | Proteasome activity enhancing compounds | Matthew Cullen, Daniel Parks, Benito Munoz | 2025-06-03 |
| 11958873 | Proteasome activity enhancing compounds | Matthew Cullen, Sheila Hauck, Bolin Geng, Megan Foley, Benito Munoz +2 more | 2024-04-16 |
| 11560385 | Proteasome activity enhancing compounds | Matthew Cullen, Daniel Parks, Benito Munoz | 2023-01-24 |
| 11248010 | Compounds, compositions, and methods for modulating CFTR | Benito Munoz, Daniel Parks | 2022-02-15 |
| 11242361 | Proteasome activity enhancing compounds | Matthew Cullen, Sheila Hauck, Bolin Geng, Megan Foley, Benito Munoz +2 more | 2022-02-08 |
| 11136313 | Compounds, compositions, and methods for modulating CFTR | Benito Munoz, Daniel Parks, David Kombo | 2021-10-05 |
| 11098035 | Compounds, compositions, and methods for increasing CFTR activity | Benito Munoz, Bradley Tait | 2021-08-24 |
| 11083709 | Compounds, compositions, and methods of increasing CFTR activity | Benito Munoz, John D. Miller | 2021-08-10 |
| 10899751 | Compounds, compositions, and methods for increasing CFTR activity | Daniel Parks, Matthew Cullen, Benito Munoz | 2021-01-26 |
| 10738011 | Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis | Benito Munoz, Bradley Tait | 2020-08-11 |
| 10738040 | Compounds, compositions, and methods for increasing CFTR activity | Benito Munoz, Bradley Tait | 2020-08-11 |
| 10662207 | Compounds, compositions, and methods for modulating CFTR | Benito Munoz, Daniel Parks | 2020-05-26 |
| 10550106 | Compounds, compositions, and methods for modulating CFTR | Benito Munoz, Daniel Parks, David Kombo | 2020-02-04 |
| 10548878 | Compounds, compositions, and methods of increasing CFTR activity | Benito Munoz, John D. Miller | 2020-02-04 |
| 10392378 | Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis | Benito Munoz, Bradley Tait | 2019-08-27 |
| 10392372 | Compounds, compositions, and methods for increasing CFTR activity | Benito Munoz, Bradley Tait | 2019-08-27 |
| 10344023 | Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis | Benito Munoz, Bradley Tait | 2019-07-09 |
| 10174014 | Compounds, compositions, and methods for increasing CFTR activity | Benito Munoz, Bradley Tait | 2019-01-08 |
| 10017503 | Compounds, compositions, and methods for increasing CFTR activity | Benito Munoz, Bradley Tait | 2018-07-10 |
| 9850262 | Proteasome activity enhancing compounds | Matthew Cullen, Sheila Hauck, Bolin Geng, Megan Foley, Benito Munoz +1 more | 2017-12-26 |
| 9790219 | Compounds, compositions, and methods for increasing CFTR activity | Benito Munoz, Bradley Tait | 2017-10-17 |
| 9745294 | 2-acylaminopropoanol-type glucosylceramide synthase inhibitors | Craig Siegel, David J. Harris, Angeles Dios, Edward R. Lee, Richard A. Silva +8 more | 2017-08-29 |
| 9745292 | Compounds, compositions, and methods for increasing CFTR activity | Benito Munoz, Bradley Tait | 2017-08-29 |
| 9744153 | 2-acylaminopropoanol-type glucosylceramide synthase inhibitors | Craig Siegel, David J. Harris, Angeles Dios, Edward R. Lee, Richard A. Silva +8 more | 2017-08-29 |
| 9272996 | 2-acylaminopropoanol-type glucosylceramide synthase inhibitors | Craig Siegel, David J. Harris, Angeles Dios, Edward R. Lee, Richard A. Silva +8 more | 2016-03-01 |